A study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of AZD5718 after single and multiple ascending dose administration to healthy Japanese men

Trial Identifier: D7550C00004
Sponsor: AstraZeneca
NCTID:: NCT03400488
Start Date: January 2018
Primary Completion Date: June 2018
Condition: Coronary Artery Disease

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Translation

Trial Locations

Country Location
United States of America, CA Glendale, CA, United States of America, 91206